Report Code: A13370 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Metformin Hydrochloride is class of biguanide and it is an anti-hyperglycemic agent. This drug acts primarily by decreasing endogenous hepatic output of glucose by inhibition of gluconeogenesis. Metformin hydrochloride is a white colored crystalline powder which is soluble in water and insoluble in chloroform, acetone, and ether. This drug is used in management of blood sugar level in patients suffering from type 2 diabetes. Metformin hydrochloride is also used as a second line agent for infertility in those patient with polycystic ovary syndrome. Moreover, metformin hydrochloride also reduces the insulin requirement in type 1 diabetes patients. Bigmet, Benformin, Comet, Glucomin, Informet, and others are some products of available metformin hydrochloride tablets in the market.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the metformin hydrochloride market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, Sun Pharma announced launch of RIOMET ER oral suspension in U.S. This product contains metformin hydrochloride extended release oral suspension and it is a first & only U.S. FDA approved extended release liquid formulation of metformin for treatment of type-2 diabetes.
In 2019, Glenmark Pharmaceuticals Inc. announced approval for launch of metformin hydrochloride extended release tablet USP 500 mg and 1000mg. This drug can be used in treatment type-2 diabetes.
In 2018, AstraZeneca India announced launch of Xigduo XR tablet contain metformin HCL & dapagliflozin. This tablet is used in type 2 diabetes management.
Key Benefits of the Report
Questions Answered in the Metformin Hydrochloride Market Report
Metformin Hydrochloride Market Report Highlights
Aspects | Details |
---|---|
By Product Type |
|
By Application |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Wanbury, Vistin Pharma, Keyuan Pharmaceutical, Farmhispania Group, Shijiazhuang Polee Pharmaceutical, USV, Shouguang Fukang Pharmaceutical, Harman Finochem, Exemed Pharmaceuticals, CR Double-Crane, Aarti Drugs |
Loading Table Of Content...
Start reading.
This Report and over 71,233+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers